Sodium-glucose cotransporter-2 inhibitor use prior to the onset of COVID-19 infection was associated with the lowest risk for adverse outcomes in patients with diabetes.
Janelle Barowski, MSN RN
Janelle Barowski, MSN RN, is a medical writer who received her Master’s degree in Nursing. She lives in New Hampshire and works at her medical writing company: Willow Bark Health Writing. Janelle continues to work at the bedside as a pediatric nurse. Follow her on LinkedIn to learn more.